Clinical
Trials
Finder
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Search
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Conditions
HER2 Positive Early Breast Cancer
Tübingen, Baden-Wurttemberg
HER2 Positive Early Breast Cancer Clinical Trials in Tübingen, Baden-Wurttemberg
1 recruiting
Tübingen, Baden-Wurttemberg, Germany
Showing
1–1
of
1
trials
Recruiting
Phase 2
NeoAdjuvant Therapy With Trastuzumab-deruxtecan Versus Chemotherapy+Trastuzumab+Pertuzumab in HER2+ Early Breast Cancer
HER2 Positive Early Breast Cancer
West German Study Group
702 enrolled
44 locations
NCT05704829
Feedback